Translating Stem Cell Science into Cell-Based Products for Clinical Trials – Strategies, Best Practices, and Regulatory Considerations

September 27, 2010 - September 28, 2010

2nd Annual Symposium - Scholarships available to UCSF Postdocs

Topics include:

  • Investigational New Drug (IND) development for cell, tissue, and gene therapies
  • Stem cell characterization and assay development
  • Cell source selection, qualification, banking, and testing
  • Preclinical animal studies:  efficacy and safety
  • FDA regulatory requirements & regulatory process
  • Development of good manufacturing practice (GMP)
  • Standards for manufacturing, ancillary reagents, and biomaterials
  • Novel approaches for tissue and organ regeneration

Speakers: Include representatives from academia, industry, and the FDA - View the program

Date: September 27-28, 2010

Location: Mission Bay Conference Center at UCSF, Conference Center 

Targeted to: Scientists and physicians interested in learning the “nuts and bolts” of translating stem cell science into cell-based products for clinical trials 

Fees: Apply, partial scholarships available to UCSF Postdocs – Application deadline September 13, 2010

Learn more

Sponsored by:


Categories: About CTSI, Research, Funding, People, Resources, Training

Accelerate is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

Cite CTSI NIH Funding Acknowledgment: Important — All publications resulting from the utilization of CTSI resources are required to credit the CTSI grant by including the NIH Funding Acknowledgment and must comply with NIH Public Access Policy.